Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial

Wiener Klinische Wochenschrift

Volumn 129, Issue 17-18, 2017, Pages 598-604

  Pfortmueller, Carmen ^a   Funk, Georg Christian ^b   Potura, Eva ^a   Reiterer, Christian ^a   Luf, Florian ^a   Kabon, Barbara ^a   Druml, Wilfred ^a   Fleischmann, Edith ^a   Lindner, Gregor ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b OTTO WAGNER HOSPITAL   (Austria)

^c KLINIK IM PARK   (Switzerland)

Author keywords

Balanced; Crystalloid; Hemodynamic; Renal transplantation; Saline

Indexed keywords

ACETATE BUFFERED CRYSTALLOID INFUSATE; ETILEFRINE; INFUSION FLUID; NORADRENALIN; PHENYLEPHRINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ACETIC ACID; CATECHOLAMINE;

ADULT; ARTERIAL PRESSURE; ARTICLE; ASSISTED CIRCULATION; CADAVER KIDNEY; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTALLOID; DIASTOLIC BLOOD PRESSURE; END STAGE RENAL DISEASE; FEMALE; HEART OUTPUT; HEMODIALYSIS; HEMODYNAMICS; HUMAN; HYPERCHLOREMIA; HYPOTENSION; INFUSION THERAPY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; MIDDLE AGED; PATIENT HISTORY OF KIDNEY TRANSPLANTATION; PERIOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; AGED; AUSTRIA; DRUG EFFECT; DRUG THERAPY; INTRAVENOUS DRUG ADMINISTRATION;

ACETATES; AGED; AUSTRIA; CATECHOLAMINES; CRYSTALLOID SOLUTIONS; FEMALE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MALE; PROSPECTIVE STUDIES; SALINE SOLUTION;

EID: 85014074965     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-017-1180-4     Document Type: Article

References (26)

1. Lobo DN. Intravenous 0.9 % saline and general surgical patients: a problem, not a solution. Ann Surg. 2012;255(5):830–2.
2. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9 % saline compared to Plasma-Lyte. Ann Surg. 2012;255(5):821–9.
3. Cecconi M, Corredor C, Arulkumaran N, Abuella G, Ball J, Grounds RM, Hamilton M, Rhodes A. Clinical review: Goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groups. Crit Care. 2013;17(2):209.
4. O’Malley CM, Frumento RJ, Bennett-Guerrero E. Intravenous fluid therapy in renal transplant recipients: results of a US survey. Transplant Proc. 2002;34(8):3142–5.
5. Noritomi DT, Pereira AJ, Bugano DD, Rehder PS, Silva E. Impact of Plasma-Lyte pH 7.4 on acid-base status and hemodynamics in a model of controlled hemorrhagic shock. Clinics (Sao Paulo). 2011;66(11):1969–74.
6. Hofmann-Kiefer KF, Chappell D, Kammerer T, Jacob M, Paptistella M, Conzen P, Rehm M. Influence of an acetate- and a lactate-based balanced infusion solution on acid base physiology and hemodynamics: an observational pilot study. Eur J Med Res. 2012;17:21.
7. Zadak Z, Hyspler R, Hronek M, Ticha A. The energetic and metabolic effect of Ringerfundin (B. Braun) infusion and comparison with Plasma-Lyte (Baxter) in healthy volunteers. Acta Medica (Hradec Kralove). 2010;53(3):131–7.
8. Voigtsberger S, Urner M, Hasler M, Roth Z’Graggen B, Booy C, Spahn DR, Beck-Schimmer B. Modulation of early inflammatory response by different balanced and non-balanced colloids and crystalloids in a rodent model of endotoxemia. PLoS ONE. 2014;9(4):e93863.
9. Story DA, Lees L, Weinberg L, Teoh SY, Lee KJ, Velissaris S, Bellomo R, Wilson SJ. Cognitive changes after saline or plasmalyte infusion in healthy volunteers: a multiple blinded, randomized, cross-over trial. Anesthesiology. 2013;119(3):569–75.
10. Keibl C, Sipos W, Ponschab M, Schlimp CJ. Blood biochemical changes in pigs after infusion with acetate-buffered or lactate-buffered crystalloid solutions. Lab Anim (NY). 2015;44(7):268–73.
11. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2‑L infusions of 0.9 % saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18–24.
12. Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001;93(4):811–6.
13. Kellum JA, Song M, Venkataraman R. Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest. 2004;125(1):243–8.
14. Potura E, Lindner G, Biesenbach P, Funk GC, Reiterer C, Kabon B, Schwarz C, Druml W, Fleischmann E. An acetate-buffered balanced crystalloid versus 0.9 % saline in patients with end-stage renal disease undergoing cadaveric renal transplantation: a prospective randomized controlled trial. Anesth Analg. 2015;120(1):123–9.
15. Liang CS, Lowenstein JM. Metabolic control of the circulation. Effects of acetate and pyruvate. J Clin Invest. 1978;62:1029–38.
16. Conahan ST, Dupre A, Giaimo ME, Fowler CA, Torres CS, Miller HI. Resuscitation fluid composition and myocardial performance during burn shock. Circ Shock. 1987;23(1):37–49.
17. Ward RA, Wathen RL, Harding GB, Thompson LC. Comparative metabolic effects of acetate and dichloroacetate infusion in the anesthetized dog. Metab Clin Exp. 1985;34(7):680–7.
18. Burnier P, Tappy L, Jequier E, Schneeberger D, Chiolero R. Metabolic and respiratory effects of infused sodium acetate in healthy human subjects. Am J Physiol. 1992;263(6 Pt 2):R1271–1276.
19. Suokas A, Kupari M, Heikkila J, Lindros K, Ylikahri R. Acute cardiovascular and metabolic effects of acetate in men. Alcohol Clin Exp Res. 1988;12(1):52–8.
20. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 1‑L infusions of 6 % hydroxyethyl starch suspended in 0.9 % saline (voluven) and a balanced solution (Plasma Volume Redibag) on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2014;259(5):881–7.
21. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566–72.
22. Nadeem A, Salahuddin N, El Hazmi A, Joseph M, Bohlega B, Sallam H, Sheikh Y, Broering D. Chloride-liberal fluids are associated with acute kidney injury after liver transplantation. Crit Care. 2014;18(6):625.
23. Krajewski ML, Raghunathan K, Paluszkiewicz SM, Schermer CR, Shaw AD. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg. 2015;102(1):24–36.
24. Raghunathan K, Shaw A, Nathanson B, Sturmer T, Brookhart A, Stefan MS, Setoguchi S, Beadles C, Lindenauer PK. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014;42(7):1585–91.
25. Burdett E, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, Grocott MP, James MF, Mythen MG, O’Malley CM, Roche AM, Rowan K. Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev. 2012;12:CD004089.
26. Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314(16):1701–10.